Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Treatment of bile duct diseases using a mini-endoscopic system

Official title: Diagnosis and Percutaneous Treatment of Biliary Tract Diseases

Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06816615 · Data updated 2026-11-12

This study is testing a new mini-endoscopic system to see if it can help people with bile duct diseases who can’t have regular endoscopic treatments.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment24 (estimated)
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Academic / other
Locations1 site (Bologna, BO)
StatusRecruiting
StartedOctober 14, 2022
Main results expectedDecember 2026
Study endsJanuary 2027
Registry record updatedFebruary 10, 2025
Trial IDNCT06816615 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 with a radiological diagnosis of gallstones or bile duct stenosis who are not eligible for endoscopic treatment.

Probably not a fit

Patients with severe untreatable coagulopathies will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on optimizing the treatment of bile duct diseases in patients who are not candidates for traditional endoscopic procedures. Participants will receive percutaneous cholangioscopic-assisted treatment using the Spyglass system at the University Hospital of Bologna. The study aims to determine if this technique can resolve biliary issues and perform biopsies more efficiently than conventional methods. It includes a 24-month enrollment phase followed by a 36-month follow-up to assess treatment outcomes.

Why it matters

Potential benefit: If successful, this approach could provide a less invasive and more effective treatment option for patients with bile duct diseases.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving outcomes for patients with biliary diseases.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Radiological diagnosis of indeterminate gallstones or stenosis of the bile ducts not eligible for endoscopic treatment and/or previous failed endoscopic treatment
* Good liver function (hemoglobin, hematocrit, GOT, GPT, GGT within normal ranges)
* Age over 18
* Obtaining informed consent

Exclusion Criteria:

* presence of severe untreatable coagulopathies

Where it's running

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna
    Bologna, Bo, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.